文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

神经调节辅助通气对重症神经脑血管病机械通气患者的影响

[Effect of neurally adjusted ventilatory assist ventilation in severe neurological cerebrovascular diseases patients undergoing mechanical ventilation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论在重症神经脑血管病机械通气患者中,NAVA模式较PSV延长28天无机械通气时间,并降低呼气潮气量、改善膈肌功能。

该前瞻性随机对照研究纳入54例神经外科ICU重症脑血管病机械通气患者,随机分为NAVA组与PSV组各27例,通气时间均≥72小时。结果显示NAVA组28天无机械通气时间显著长于PSV组[22(15,26)天 vs. 6(0,23)天,P<0.05],第3天呼气潮气量显著低于PSV组,第2天分钟通气量显著高于PSV组,第1天气道峰压和平均气道压显著低于PSV组,第2、3天膈肌增厚分数显著高于PSV组。两组总机械通气时间、90天生存率、NSICU住院时间、总住院时间、NSICU死亡率、院内死亡率、GOS评分及机械通气相关并发症发生率无显著差异。作者认为NAVA模式可应用于重症神经脑血管病患者,延长无机械通气支持时间并获得更好的肺保护性通气,在避免呼吸机相关膈肌功能障碍和改善膈肌功能方面有一定优势。

要点

  • NAVA组28天无机械通气时间显著长于PSV组[22(15,26)天 vs. 6(0,23)天,P<0.05]。
  • NAVA组第3天呼气潮气量显著低于PSV组[411.0(385.2,492.6)mL vs. 489.0(451.8,529.4)mL,P<0.01]。
  • NAVA组第2天分钟通气量显著高于PSV组[9.8(8.4,10.9)L/min vs. 7.8(6.5,9.8)L/min,P<0.01]。
  • NAVA组第1天气道峰压和平均气道压显著低于PSV组[Ppeak 14.0(12.2,17.0)cmH2O vs. 16.6(15.0,17.4)cmH2O;Pmean 7.0(6.2,7.9)cmH2O vs. 8.0(7.0,8.2)cmH2O,均P<0.05]。
  • NAVA组第2、3天膈肌增厚分数显著高于PSV组[第2天(35.18±12.09)% vs.(26.88±8.33)%,第3天(35.54±13.40)% vs.(24.39±9.16)%,均P<0.05]。

适用人群与场景

  • 2020年12月至2022年5月皖南医学院第一附属医院(弋矶山医院)神经外科ICU收治的重症神经脑血管病机械通气患者54例,随机分为NAVA组和PSV组各27例,两组通气时间均≥72小时。

研究设计与关键结果

  • 前瞻性随机对照研究,纳入54例重症神经脑血管病机械通气患者,NAVA组与PSV组各27例;NAVA组28天无机械通气时间显著长于PSV组[22(15,26)天 vs. 6(0,23)天,P<0.05]。
  • 两组总机械通气时间、90天生存率、NSICU住院时间、总住院时间、NSICU死亡率、院内死亡率、GOS评分及机械通气相关并发症发生率均无显著差异。
  • NAVA组第3天呼气潮气量显著低于本组第1天和第2天,且显著低于PSV组[411.0(385.2,492.6)mL vs. 489.0(451.8,529.4)mL,P<0.01];NAVA组第2、3天分钟通气量显著高于本组第1天,第2天显著高于PSV组[9.8(8.4,10.9)L/min vs. 7.8(6.5,9.8)L/min,P<0.01],PSV组分钟通气量无显著变化。
  • NAVA组第1天气道峰压和平均气道压显著低于PSV组[Ppeak 14.0(12.2,17.0)cmH2O vs. 16.6(15.0,17.4)cmH2O,Pmean 7.0(6.2,7.9)cmH2O vs. 8.0(7.0,8.2)cmH2O,均P<0.05];第2、3天两组Ppeak和Pmean无显著差异。
  • 两组pH值无显著差异,但随着机械通气时间延长,两组第3天pH值均显著高于第1天;NAVA组第1天动脉血氧分压显著低于PSV组[122.01±37.77 mmHg vs. 144.10±40.39 mmHg,P<0.05],第2、3天两组PaO2无显著差异;两组动脉血二氧化碳分压和氧合指数无显著差异。
  • NAVA组第1、2、3天呼吸频率均显著高于PSV组[第1天19.2(16.0,25.2)次/min vs. 15.0(14.4,17.0)次/min,第2天21.4(16.4,26.0)次/min vs. 15.8(14.0,18.6)次/min,第3天20.6(17.0,23.0)次/min vs. 16.7(15.0,19.0)次/min,均P<0.01]。
  • NAVA组第3天吸气末膈肌厚度显著高于PSV组[0.26(0.22,0.29)cm vs. 0.22(0.19,0.26)cm,P<0.05];两组呼气末膈肌厚度无显著差异;NAVA组第2、3天膈肌增厚分数显著高于PSV组[第2天(35.18±12.09)% vs.(26.88±8.33)%,第3天(35.54±13.40)% vs.(24.39±9.16)%,均P<0.05]。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,NAVA模式可应用于重症神经脑血管病机械通气患者,可延长无机械通气支持时间并使患者获得更好的肺保护性通气,同时在避免呼吸机相关膈肌功能障碍和改善膈肌功能方面具有一定优势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the prognostic effect and safety of neurally adjusted ventilatory assist (NAVA) mode on the patients with severe neurological cerebrovascular disease undergoing mechanical ventilation.

METHODS: A prospective study was conducted. Fifty-four patients with cerebrovascular disease undergoing mechanical ventilation admitted to the neurosurgery intensive care unit (NSICU) of the First Affiliated Hospital of Wannan Medical College (Yijishan Hospital) from December 2020 to May 2022 were enrolled. They were divided into NAVA group and pressure support ventilation (PSV) group by computer random number generator with 27 patients in each group. The ventilation time of the two groups was ≥ 72 hours. The general basic data of the two groups were recorded. The time without mechanical ventilation 28 days after enrollment, total length of mechanical ventilation, survival rate of 90 days after enrollment, length of NSICU stay, total length of hospital stay, NSICU mortality, in-hospital mortality, Glasgow outcome score (GOS), complications related to mechanical ventilation, and changes of respiratory mechanics indexes, arterial blood gases, vital signs, and diaphragm function indexes were observed.

RESULTS: The time without mechanical ventilation 28 days after enrollment in the NAVA group was significantly longer than that in the PSV group [days: 22 (15, 26) vs. 6 (0, 23), P < 0.05]. However, there were no significant differences in the total length of mechanical ventilation, 90-day survival rate, length of NSICU stay, total length of hospital stay, NSICU mortality, in-hospital mortality, GOS score, and incidence of mechanical ventilator-related complications between the two groups. In terms of respiratory mechanics parameters, the expiratory tidal volume (VTe) on 3 days after mechanical ventilation of patients in the NAVA group was significantly lower than that on 1 day and 2 days, and significantly lower than that in the PSV group [mL: 411.0 (385.2, 492.6) vs. 489.0 (451.8, 529.4), P < 0.01]. Minute ventilation (MV) at 2 days and 3 days in the NAVA group was significantly higher than that at 1 day, and significantly higher than that in the PSV group at 2 days [L/min: 9.8 (8.4, 10.9) vs. 7.8 (6.5, 9.8), P < 0.01], while there was no significant change of MV in the PSV group. At 1 day, peak airway pressure (Ppeak) and mean airway pressure (Pmean) in the NAVA group were significantly lower than those in the PSV group [Ppeak (cmH2O, 1 cmH2O ≈ 0.098 kPa): 14.0 (12.2, 17.0) vs. 16.6 (15.0, 17.4), Pmean (cmH2O): 7.0 (6.2, 7.9) vs. 8.0 (7.0, 8.2), both P < 0.05]. However, there was no significant difference in the Ppeak or Pmean at 2 days and 3 days between the two groups. In terms of arterial blood gas, there was no significant difference in pH value between the two groups, but with the extension of mechanical ventilation time, the pH value at 3 days of the two groups was significantly higher than that at 1 day. Arterial partial pressure of oxygen (PaO2) at 1 day in the NAVA group was significantly lower than that in the PSV group [mmHg (1 mmHg ≈ 0.133 kPa): 122.01±37.77 vs. 144.10±40.39, P < 0.05], but there was no significant difference in PaO2 at 2 days and 3 days between the two groups. There was no significant difference in arterial partial pressure of carbon dioxide (PaCO2) or oxygenation index (PaO2/FiO2) between the two groups. In terms of vital signs, the respiratory rate (RR) at 1, 2, and 3 days of the NAVA group was significantly higher than that of the PSV group [times/min: 19.2 (16.0, 25.2) vs. 15.0 (14.4, 17.0) at 1 day, 21.4 (16.4, 26.0) vs. 15.8 (14.0, 18.6) at 2 days, 20.6 (17.0, 23.0) vs. 16.7 (15.0, 19.0) at 3 days, all P < 0.01]. In terms of diaphragm function, end-inspiratory diaphragm thickness (DTei) at 3 days in the NAVA group was significantly higher than that in the PSV group [cm: 0.26 (0.22, 0.29) vs. 0.22 (0.19, 0.26), P < 0.05]. There was no significant difference in end-expiratory diaphragm thickness (DTee) between the two groups. The diaphragm thickening fraction (DTF) at 2 days and 3 days in the NAVA group was significantly higher than that in the PSV group [(35.18±12.09)% vs. (26.88±8.33)% at 2 days, (35.54±13.40)% vs. (24.39±9.16)% at 3 days, both P < 0.05].

CONCLUSIONS: NAVA mode can be applied in patients with neuro-severe cerebrovascular disease, which can prolong the time without mechanical ventilation support and make patients obtain better lung protective ventilation. At the same time, it has certain advantages in avoiding ventilator-associated diaphragm dysfunction and improving diaphragm function.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang K, Tang Y, Tao X, et al. [Effect of neurally adjusted ventilatory assist ventilation in severe neurological cerebrovascular diseases patients undergoing mechanical ventilation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916379. doi:10.3760/cma.j.cn121430-20220822-00771

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。